Better late than never: Delayed asparaginase during induction for acute lymphoblastic leukaemia in adults

Paediatric regimens which incorporate asparaginase have improved outcomes of adolescents and younger adults with acute lymphoblastic leukaemia but are limited by toxicity. This retrospective report by Tinajero and Xu suggests that delaying the timing of asparaginase administration during ALL induction may reduce risk of hepatotoxicity. Commentary on: Tinajero et al. Delaying pegaspargase during induction in adults with acute lymphoblastic leukaemia is associated with lower risk of high-grade hepatotoxicity without adversely impacting outcomes. Br J Haematol 2025; 206:868-875.

Authors

Institutions

Publication Details

Journal
British Journal of Haematology
Published
2024-11-24
DOI
https://doi.org/10.1111/bjh.19928
Primary Topic
Acute Lymphoblastic Leukemia research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Better late than never: Delayed asparaginase during induction for acute lymphoblastic leukaemia in adults

Marlise Rachael Luskin, Yannis K. Valtis
British Journal of Haematology
Acute Lymphoblastic Leukemia research
article

Better late than never: Delayed asparaginase during induction for acute lymphoblastic leukaemia in adults

Marlise Rachael Luskin, Yannis K. Valtis
article en

Abstract

Paediatric regimens which incorporate asparaginase have improved outcomes of adolescents and younger adults with acute lymphoblastic leukaemia but are limited by toxicity. This retrospective report by Tinajero and Xu suggests that delaying the timing of asparaginase administration during ALL induction may reduce risk of hepatotoxicity. Commentary on: Tinajero et al. Delaying pegaspargase during induction in adults with acute lymphoblastic leukaemia is associated with lower risk of high-grade hepatotoxicity without adversely impacting outcomes. Br J Haematol 2025; 206:868-875.

British Journal of HaematologyVol. 206(3)
Memorial Sloan Kettering Cancer Center (US), Dana-Farber Cancer Institute (US)
Good health and well-being
Openalex Percentile: Top 68%
Acute Lymphoblastic Leukemia research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.